Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Name: Medpace Holdings Inc: Is Infosys Ltd. worth buying?
Item: Medpace Holdings Inc
Rating: 1.780430625
Author: Trendlyne DVM scores

Expensive Performer

about

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

419.17 -4.59 (-1.08%)

33.35% Fall from 52W High

239.0K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The board meeting for Medpace Holdings Inc is scheduled for today, for the purpose of Medpace Holdings Inc Annual General Meeting for 2026 See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

28.2 / 100

Technically Neutral

36.5 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

443

1Yr Price target upside is 6%

12 analysts

Medpace Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

33.35% Fall from 52W High

SWOT Analysis

Medpace Holdings Inc Live Price Chart